Adipose Tissue-Derived Plasminogen Activator Inhibitor-1 Function and Regulation. (Q51361802)

4 April 2018

review article

1 reference

title

Adipose Tissue-Derived Plasminogen Activator Inhibitor-1 Function and Regulation. (English)

1 reference

4 April 2018

1 reference

Hiroshi Kaji

1

1 reference

4 April 2018

publication date

15 September 2016

1 reference

4 April 2018

published in

Comprehensive Physiology

1 reference

4 April 2018

volume

6

1 reference

4 April 2018

page(s)

1873-1896

1 reference

4 April 2018

issue

4

1 reference

4 April 2018

Obesity and diabetes: the link between adipose tissue dysfunction and glucose homeostasis.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Comprehensive analysis of circulating adipokines and hsCRP association with cardiovascular disease risk factors and metabolic syndrome in Arabs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Adipose mesenchymal stromal cells isolated from type 2 diabetic patients display reduced fibrinolytic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Enhanced functional stability of plasminogen activator inhibitor-1 in patients with livedoid vasculopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Parametrial adipose tissue and metabolic dysfunctions induced by fructose-rich diet in normal and neonatal-androgenized adult female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Obesity and dementia: adipokines interact with the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Characterization of In Vitro Engineered Human Adipose Tissues: Relevant Adipokine Secretion and Impact of TNF-α.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

TNF-α upregulates sclerostin expression in obese mice fed a high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Metabolic factors, adipose tissue, and plasminogen activator inhibitor-1 levels in type 2 diabetes: findings from the look AHEAD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

The plasma levels of prostanoids and plasminogen activator inhibitor-1 in primary and secondary thrombocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Leptin and resistin induce increased procoagulability in diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Adipose tissue dysregulation in patients with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Characterization of a novel class of polyphenolic inhibitors of plasminogen activator inhibitor-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Fructose rich diet-induced high plasminogen activator inhibitor-1 (PAI-1) production in the adult female rat: protective effect of progesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Accelerated skin wound healing in plasminogen activator inhibitor-1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Increased GIP signaling induces adipose inflammation via a HIF-1α-dependent pathway and impairs insulin sensitivity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Identification and localization of a fatty acid response region in the human plasminogen activator inhibitor-1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Biochemistry of adipose tissue: an endocrine organ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Adverse effects of glucocorticoids: coagulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Adipokines: biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Improved autograft survival of mesenchymal stromal cells by plasminogen activator inhibitor 1 inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Identification and importance of brown adipose tissue in adult humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Plasminogen activator inhibitors regulate cell adhesion through a uPAR-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

PAI-1: An Integrator of Cell Signaling and Migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Increased bone formation in mice lacking plasminogen activators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Implication of low level inflammation in the insulin resistance of adipose tissue at late pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Mediators of chronic inflammation in polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Increased PAI-1 in females compared with males is protective for abdominal aortic aneurysm formation in a rodent model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Disturbed angiogenic activity of adipose-derived stromal cells obtained from patients with coronary artery disease and diabetes mellitus type 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Adipose-derived mesenchymal stromal cells from aged patients with coronary artery disease keep mesenchymal stromal cell properties but exhibit characteristics of aging and have impaired angiogenic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

The association of clot lysis time with total obesity is partly independent from the association of PAI-1 with central obesity in African adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Plasminogen activator inhibitor 1--insulin-like growth factor binding protein 3 cascade regulates stress-induced senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Blood coagulation and fibrinolysis in patients with Cushing's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

PAI-1-regulated extracellular proteolysis governs senescence and survival in Klotho mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Age-dependent spontaneous coronary arterial thrombosis in transgenic mice that express a stable form of human plasminogen activator inhibitor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Fatty acid-induced production of plasminogen activator inhibitor-1 by adipose macrophages is greater in middle-aged versus younger adult participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Monocyte chemoattractant protein 1 expression is stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Age and sex mediated changes in epicardial fat adipokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Plasminogen activator inhibitor-1 and restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Brown fat lipoatrophy and increased visceral adiposity through a concerted adipocytokines overexpression induces vascular insulin resistance and dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Angiotensin II receptor blocker ameliorates stress-induced adipose tissue inflammation and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Evaluation of PAI-039 [{1-benzyl-5-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic acid], a novel plasminogen activator inhibitor-1 inhibitor, in a canine model of coronary artery thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

LRP: a multifunctional scavenger and signaling receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

The plasminogen fibrinolytic pathway is required for hematopoietic regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

The inhibitory effect of pterostilbene on inflammatory responses during the interaction of 3T3-L1 adipocytes and RAW 264.7 macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Therapeutic value of small molecule inhibitor to plasminogen activator inhibitor-1 for lung fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Inhibition of plasminogen activator inhibitor type-1 activity enhances rapid and sustainable hematopoietic regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Inhibition of plasminogen activator inhibitor-1: its mechanism and effectiveness on coagulation and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Moderate alcohol consumption diminishes the development of non-alcoholic fatty liver disease (NAFLD) in ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

MicroRNA-30c promotes human adipocyte differentiation and co-represses PAI-1 and ALK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

The Tissue Fibrinolytic System Contributes to the Induction of Macrophage Function and CCL3 during Bone Repair in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Tissue-type plasminogen activator deficiency delays bone repair: roles of osteoblastic proliferation and vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Increased Abdominal Adiposity in Adolescents and Young Adults With Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Adipocyte-derived factors potentiate nutrient-induced production of plasminogen activator inhibitor-1 by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Ubiquitin-specific protease 2-69 in macrophages potentially modulates metainflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Adipocyte exosomes induce transforming growth factor beta pathway dysregulation in hepatocytes: a novel paradigm for obesity-related liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Significant differential effects of lower doses of hormone therapy or tibolone on markers of cardiovascular disease in post-menopausal women: a randomized, double-blind, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Mice deficient in plasminogen activator inhibitor-1 have improved skeletal muscle regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Inhibition of plasminogen activator inhibitor-1 restores skeletal muscle regeneration in untreated type 1 diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Oxidized LDL and lysophosphatidylcholine stimulate plasminogen activator inhibitor-1 expression through reactive oxygen species generation and ERK1/2 activation in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Simple steatosis is a more relevant source of serum inflammatory markers than omental adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Plasminogen activator inhibitor-1 modulates adipocyte differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Pleiotropic functions of plasminogen activator inhibitor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Nutritionally induced obesity is attenuated in transgenic mice overexpressing plasminogen activator inhibitor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Ectopic fat and cardiometabolic and vascular risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Plasminogen activator/plasminogen activator inhibitors in ovarian physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Plasminogen activator inhibitor type-1 inhibits insulin signaling by competing with alphavbeta3 integrin for vitronectin binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Structure of the human plasminogen activator inhibitor 1 gene: nonrandom distribution of introns

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Review article: The role of adipose tissue in uraemia-related insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Plasminogen activator inhibitor-1 is involved in impaired bone repair associated with diabetes in female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

The effect of weight loss magnitude on pro-/anti-inflammatory adipokines and carotid intima-media thickness in obese adolescents engaged in interdisciplinary weight loss therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Obesity, inflammation, and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Attenuated adiposopathy in perivascular adipose tissue compared with subcutaneous human adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Relationship of thoracic fat depots with coronary atherosclerosis and circulating inflammatory biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Plasminogen activator inhibitor type-1 is an independent marker of metabolic disorders in young adults born small for gestational age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Young Hispanics at risk of type 2 diabetes display endothelial activation, subclinical inflammation and alterations of coagulation and fibrinolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

FOXO1 involvement in insulin resistance-related pro-inflammatory cytokine production in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Inhibition of gastric inhibitory polypeptide signaling prevents obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Cardiovascular disease-related parameters and oxidative stress in SHROB rats, a model for metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

All-trans retinoic acid displays multiple effects on the growth, lipogenesis and adipokine gene expression of AML-I preadipocyte cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

beta3-adrenergic receptor induction of adipocyte inflammation requires lipolytic activation of stress kinases p38 and JNK

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Plasminogen activator inhibitor type 1 up-regulation is associated with skeletal muscle atrophy and associated fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Adipocyte-derived factors regulate vascular smooth muscle cells through mineralocorticoid and glucocorticoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Spatial redox regulation of a critical cysteine residue of NF-kappa B in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

IRAP deficiency attenuates diet-induced obesity in mice through increased energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Transgenic over-expression of plasminogen activator inhibitor-1 results in age-dependent and gender-specific increases in bone strength and mineralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Plasminogen activator inhibitor-1 and the circadian clock in metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Tissue-specific augmentation of circadian PAI-1 expression in mice with streptozotocin-induced diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Erythropoietin improves insulin resistance via the regulation of its receptor-mediated signaling pathways in 3T3L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Alterations in the common pathway of coagulation during weight loss induced by gastric bypass in severely obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Aucubin, a naturally occurring iridoid glycoside inhibits TNF-α-induced inflammatory responses through suppression of NF-κB activation in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Inflammatory cytokines interleukin-6 and oncostatin m induce plasminogen activator inhibitor-1 in human adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Fracture healing in mice deficient in plasminogen activator inhibitor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Androgen therapy in men with testosterone deficiency: can testosterone reduce the risk of cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Human epicardial adipose tissue: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Oncostatin m is produced in adipose tissue and is regulated in conditions of obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Circadian activity of the endogenous fibrinolytic system in stable coronary artery disease: effects of beta-adrenoreceptor blockers and angiotensin-converting enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Adipokines and thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Reciprocal regulation of tissue-type and urokinase-type plasminogen activators in the differentiation of murine preadipocyte line 3T3-L1 and the hormonal regulation of fibrinolytic factors in the mature adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Epicardial adipose tissue volume and adipocytokine imbalance are strongly linked to human coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

α₂-Antiplasmin is involved in bone loss induced by ovariectomy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Diet-induced adipose tissue inflammation and liver steatosis are prevented by DPP-4 inhibition in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Adipose tissue secretion and expression of adipocyte-produced and stromavascular fraction-produced adipokines vary during multiple phases of weight-reducing dietary intervention in obese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Distribution of plasminogen activator inhibitor (PAI-1) in tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Leptin upregulates the expression of plasminogen activator inhibitor-1 in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Increased expression of plasminogen activator inhibitor-1 in cardiomyocytes contributes to cardiac fibrosis after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Plasminogen activator inhibitor-1 is involved in streptozotocin-induced bone loss in female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Plasminogen activator inhibitor-1 deficiency ameliorates insulin resistance and hyperlipidemia but not bone loss in obese female mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Role of plasminogen activator inhibitor-1 in glucocorticoid-induced diabetes and osteopenia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Connective tissue growth factor/CCN-2 is upregulated in epididymal and subcutaneous fat depots in a dietary-induced obesity model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Plasminogen activator inhibitor-1 and thrombotic cerebrovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3-TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Stress augments insulin resistance and prothrombotic state: role of visceral adipose-derived monocyte chemoattractant protein-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

The influence of sodium- and calcium-regulatory hormone interventions on adipocytokines in obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

The Biochemistry, Physiology and Pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Characterization of the inflammatory and metabolic profile of adipose tissue in a mouse model of chronic hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Angiotensin and vascular fibrinolytic balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Biology of arterial atheroma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Determining the association between adipokine expression in multiple tissues and phenotypic features of non-alcoholic fatty liver disease in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Plasminogen activator inhibitor-1 is a major stress-regulated gene: implications for stress-induced thrombosis in aged individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Effects of voluntary running and soy supplementation on diet-induced metabolic disturbance and inflammation in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Effects of a high-fat diet on spontaneous metastasis of Lewis lung carcinoma in plasminogen activator inhibitor-1 deficient and wild-type mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Brown adipose tissue, whole-body energy expenditure, and thermogenesis in healthy adult men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

"Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Resveratrol suppresses PAI-1 gene expression in a human in vitro model of inflamed adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Epigallocatechin-3-O-gallate (EGCG) protects the insulin sensitivity in rat L6 muscle cells exposed to dexamethasone condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Fat cell size and adipokine expression in relation to gender, depot, and metabolic risk factors in morbidly obese adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Stimulated in vivo synthesis of plasminogen activator inhibitor-1 in human adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

A Role for Plasminogen Activator Inhibitor-1 in Obesity: From Pie to PAI?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

Imbalance between protective (adiponectin) and prothrombotic (Plasminogen Activator Inhibitor-1) adipokines in metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

Progression of symptomatic intracranial large artery atherosclerosis is associated with a proinflammatory state and impaired fibrinolysis

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

Mice lacking the plasminogen activator inhibitor 1 are protected from trabecular bone loss induced by estrogen deficiency

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

Insulin resistance induced by hydrocortisone is increased in patients with abdominal obesity

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

Metabolic, hormonal and environmental regulation of plasminogen activator inhibitor-1 (PAI-1) expression: lessons from the liver

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

Plasminogen activator inhibitor-1 controls bone marrow-derived cells therapeutic effect through MMP9 signaling: role in physiological and pathological wound healing

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

Plasminogen activator inhibitor-1 overexpression in nonproliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk.

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

Plasminogen plays a crucial role in bone repair

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

Do PAI-1 and vitronectin promote or inhibit neointima formation? The exact role of the fibrinolytic system in vascular remodeling remains uncertain

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

Atorvastatin and fenofibric acid differentially affect the release of adipokines in the visceral and subcutaneous cultures of adipocytes that were obtained from patients with and without mixed dyslipidemia

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

Caloric restriction improves coagulation and inflammation profile in obese mice

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

Haemostatic function in patients undergoing coronary artery bypass grafting: peroperative perturbations and relations to saphenous vein graft closure

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

Plasminogen activator inhibitor-1 and haemostasis in obesity.

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

Associations between plasma PAI-1 concentrations and its expressions in various organs in obese model mice

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

Food deprivation induces adipose plasminogen activator inhibitor-1 (PAI-1) expression without accumulation of plasma PAI-1 in genetically obese and diabetic db/db mice.

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

Antiplatelet therapy effectively reduces plasma plasminogen activator inhibitor-1 levels

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

Disruption of the plasminogen activator inhibitor 1 gene reduces the adiposity and improves the metabolic profile of genetically obese and diabetic ob/ob mice.

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

Enhanced thrombosis in atherosclerosis-prone mice is associated with increased arterial expression of plasminogen activator inhibitor-1

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

Effect of plasminogen activator inhibitor-1 on adipogenesis in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

Quantitative expression of protein markers of plasminogen activation system in prognosis of colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

High-Fat Diets Containing Different Amounts of n3 and n6 Polyunsaturated Fatty Acids Modulate Inflammatory Cytokine Production in Mice

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

Increased expression of plasminogen activator inhibitor-1 with fibrin deposition in a murine model of aging, "Klotho" mouse

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

Inhibition of PAI-1 induces neutrophil-driven neoangiogenesis and promotes tissue regeneration via production of angiocrine factors in mice

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

Effects of tibolone and continuous combined hormone replacement therapy on parameters in the clotting cascade: a multicenter, double-blind, randomized study

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

Pitavastatin attenuates the upregulation of tissue factor in restraint-stressed mice

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C160004

7 January 2021

Identifiers

DOI

10.1002/CPHY.C160004

1 reference

4 April 2018

PubMed ID

27783862

1 reference

4 April 2018